Evidence map›Paper›PMID 41127843›Full record

ArticleEnvironment & health (Washington, D.C.)2025

Exposure Levels and Health Risks of Phthalate Alternatives: A Urinary Metabolite Study.

Jing Ren, Qingqing Zhu, Chunyang Liao, Guibin Jiang

Abstract read
In one paragraph

Article in Environment & health (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jing RenDepartment of Chemistry, College of Sciences, Northeastern University, Shenyang 110819, China.
Qingqing ZhuState Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.ORCID https://orcid.org/0000-0002-6207-799X
Chunyang LiaoState Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.ORCID https://orcid.org/0000-0003-2846-6614
Guibin JiangDepartment of Chemistry, College of Sciences, Northeastern University, Shenyang 110819, China.ORCID https://orcid.org/0000-0002-6335-3917

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phthalate alternatives are increasingly replacing traditional phthalates (PAEs) as plasticizers due to growing regulatory and health concerns. However, these alternatives and their metabolites have been detected in both environmental and biological matrices, raising concerns regarding potential health risks. Here, we used ultrahigh performance liquid chromatography-tandem mass spectrometry to detect nine metabolites of four PAE alternatives (aPAEs) in 176 urine samples collected from residents of Chengdu and Suining, Sichuan Province, China. Our results revealed that seven metabolites were commonly present in the urine samples, with total metabolite concentrations ranging from 2.52 to 6300 ng/mL. The median concentrations were 21.1 ng/mL in Chengdu and 39.8 ng/mL in Suining. The compositional profiles of these metabolites in urine samples from both cities were similar, with mono-2-ethyl-5-carboxypentyl terephthalate (MECPTP) identified as the predominant metabolite, representing over 50% of the total concentration. Notably, teenagers exhibited higher exposure levels compared to other age groups. Despite these findings, the estimated internal exposures remained well below health-based guidance values and toxicological reference levels, suggesting that the current exposure level may not pose acute health risks. This study highlights the widespread occurrence of aPAE metabolites in human urine and underscores continued biomonitoring and risk assessment of these emerging pollutants.

Indexed as

Health riskHuman exposureMetabolitesPhthalate alternativesUrine

Identifiers

PMID41127843
PMCPMC12538321

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.